HIGHLIGHTS
- who: Verena Schu00f6ning and Felix Hammann from the Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University, University of Bern, Bern, Switzerland have published the research: Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
- what: The aim of this study was to analyze the impact of DDSIs and TDSIs on COVID-19 In Table S2, the authors show nodes with the greatest differences in the betweenness between the cohorts.
- how: The authors identified . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.